Neuroleptic Malignant Syndrome: What It Is, Symptoms, Causes & Treatments

Written by Medicover Team and Medically Reviewed by Dr Prachi Rahul Pawar , Neurologists

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Neuroleptic Malignant Syndrome (NMS) is a rare but life-threatening condition that is often associated with the use of antipsychotic medications. It requires prompt diagnosis and treatment to mitigate severe complications or death.

Neuroleptic Malignant Syndrome is a severe reaction to neuroleptic or antipsychotic medications. It is characterized by hyperthermia, muscle rigidity, autonomic dysfunction, and altered mental status. The condition can escalate rapidly, making immediate medical intervention crucial.

What Are the Different Types of Neuroleptic Malignant Syndrome?

NMS can vary in presentation and severity, leading to different classifications:

Classic NMS: Presents with the full spectrum of symptoms.
Atypical NMS: May lack one or more of the classic symptoms, making diagnosis more challenging.
Mild NMS:Exhibits milder symptoms, often leading to delayed diagnosis.

What Are the Symptoms of Neuroleptic Malignant Syndrome?

Recognition of NMS symptoms is critical for timely diagnosis and treatment. The hallmark symptoms include:

Hyperthermia: Elevated body temperature often exceeding 38Â°C (100.4Â°F).
Muscle Rigidity: Generalized, severe muscle stiffness.
Autonomic Dysfunction: Fluctuations in blood pressure, tachycardia, diaphoresis, and dysphagia.
Altered Mental Status: Confusion, agitation, delirium, or even coma.

What Causes Neuroleptic Malignant Syndrome?

NMS is most commonly triggered by neuroleptic or antipsychotic medications, including typical and atypical antipsychotics. Certain antiemetics and medications that reduce dopamine activity may also increase the risk of developing this condition.

Drugs Causing Neuroleptic Malignant Syndrome

Several drugs are known to precipitate NMS, including:

Typical Antipsychotics: Such as haloperidol and chlorpromazine.
Atypical Antipsychotics: Including risperidone and olanzapine.
Other Medications: Such as antiemetics like metoclopramide and certain antidepressants.

When Should You See a Doctor for Neuroleptic Malignant Syndrome?

Seek immediate medical attention from an neurologist if you develop symptoms suggestive of Neuroleptic Malignant Syndrome (NMS), particularly after starting or increasing the dose of an antipsychotic medication.

High fever after starting or increasing an antipsychotic medication
Severe muscle stiffness or rigidity
Confusion, agitation, or reduced consciousness
Rapid heartbeat or unstable blood pressure
Excessive sweating or difficulty swallowing
Symptoms that worsen rapidly over a few hours or days

Neuroleptic Malignant Syndrome is a medical emergency. Early diagnosis and immediate treatment can prevent life-threatening complications and significantly improve recovery.

Find Neurologists for Neuroleptic Malignant Syndrome Treatment Near You

How Is Neuroleptic Malignant Syndrome Diagnosed?

Diagnosis is based on clinical symptoms, medication history, physical examination, blood tests, elevated creatine phosphokinase (CPK), white blood cell count, electrolyte analysis, and exclusion of conditions with similar symptoms.

Clinical Criteria

The diagnosis of NMS is primarily clinical, based on the presence of characteristic symptoms and history of neuroleptic medication use. The following criteria are often used:

Major Criteria: Hyperthermia, muscle rigidity, and autonomic instability.
Minor Criteria: Altered mental status, elevated creatine phosphokinase (CPK), leukocytosis, and metabolic acidosis.

Laboratory Tests

Several laboratory tests can support the diagnosis:

Elevated CPK Levels: Indicative of muscle breakdown.
Leukocytosis: Elevated white blood cell count.
Electrolyte Imbalance: Such as elevated potassium and low calcium levels.

Differential Diagnosis

It is crucial to distinguish NMS from other conditions with similar presentations, such as serotonin syndrome, malignant hyperthermia, and severe infections like sepsis.

What Are the Treatment Options for Neuroleptic Malignant Syndrome?

Treatment begins with immediately stopping the offending medication, followed by intensive supportive care. Management may include cooling measures, intravenous fluids, electrolyte correction, and medications such as dantrolene, bromocriptine, or amantadine.

Immediate Interventions

The primary goal is to discontinue the offending neuroleptic agent immediately. Supportive care in an intensive care unit (ICU) is often required:

Cooling Measures: To reduce hyperthermia.
Hydration: To prevent dehydration and renal failure.
Electrolyte Management: To correct imbalances.

Pharmacological Treatment

Dantrolene: A muscle relaxant that helps reduce rigidity and hyperthermia.
Bromocriptine: A dopamine agonist that can counteract dopamine receptor blockade.
Amantadine: Another dopamine agonist that may be beneficial.

Long-term Management

After the acute phase, careful consideration is needed before reintroducing neuroleptic medications. Alternative treatments or lower doses may be explored to minimize the risk of recurrence.

Your health is everything - prioritize your well-being today.

Consult Neuroleptic Malignant Syndrome Doctors Today

How Can Neuroleptic Malignant Syndrome Be Prevented?

Prevention involves gradual dose adjustments of antipsychotic medications, avoiding rapid dose escalation, maintaining adequate hydration, monitoring high-risk patients, and recognising early warning signs to allow prompt medical intervention.

Risk Reduction Strategies

Gradual Dose Titration: Avoid rapid escalation of neuroleptic doses.
Adequate Hydration: Ensure patients are well-hydrated, especially during hot weather.
Close Monitoring: Regular monitoring of patients who are starting or changing neuroleptic medications.

Patient Education

Educating patients and caregivers about the early signs of NMS can lead to prompt medical attention and intervention, potentially preventing severe outcomes.

What Are the Risk Factors for Neuroleptic Malignant Syndrome?

Certain factors may increase the risk of developing NMS:

High Potency Antipsychotics: Higher doses or rapid dose escalation.
Dehydration: Increases susceptibility to hyperthermia.
Pre Existing Medical Conditions: Such as Parkinson's disease or other movement disorders.